WILMINGTON, Del., June 27, 2024 (GLOBE NEWSWIRE) — The Akkermansia Company, creators of next-generation clinically proven gut health solutions, announces its entry into the U.S. consumer market. The company's founders first discovered and sequenced Akkermansia muciniphila, a bacterium responsible for protecting the intestinal barrier to support optimal health and longevity.
Akkermansia muciniphila is naturally present in a healthy gut, but many people have low levels, which can cause leaky gut and inflammation that can lead to obesity, diabetes, cardiovascular disease and other health problems.
To solve this problem, Akkermansia has developed a dietary supplement containing scientifically-backed ingredients that replenish low levels of Akkermansia muciniphila and protect and restore the intestinal barrier.
This supplement was born after many years of research. In 2004, Akkermansia Company co-founder Professor Willem M. de Vos and his team at Wageningen University first discovered Akkermansia muciniphila.
Under the supervision of Professor de Vos, PhD student Dr Muriel Derrien successfully isolated and characterised Akkermansia muciniphila and the team named the strain in honour of renowned microbial ecologist Dr Anton Akkermans, who works in the Wageningen lab.
Professor de Vos' team then developed pasteurized Akkermansia muciniphila MucT™, the only Akkermansia strain that has been clinically studied in humans.
A 2019 human volunteer study showed that daily administration of pasteurized Akkermansia muciniphila MucT™ for three months was safe and effectively improved intestinal barrier function. This postbiotic offers superior stability and contains up to 100 times more bioavailable Akkermansia muciniphila than commercially available probiotic products.
“After years of research and human clinical trials, we have created the most biologically effective form of Akkermansia muciniphila,” said Professor de Vos. “Our proprietary pasteurized strain, Akkermansia muciniphila MucT™, is a safe, clinically proven breakthrough in gut and microbiome health. It has been carefully designed and proven to support optimal health and longevity. Further clinical data will be published later this year.”
The Akkermansia Company's first supplement to be sold in the U.S., Healthy Weight, contains pasteurized Akkermansia muciniphila MucT™, which strengthens the intestinal barrier, plus EGCG green tea and chromium to promote weight management and support longevity and vitality.
Healthy Weight has been available in Europe since 2021. It's currently on sale on Amazon for $59.99 for a 30-day supply.
For more information about The Akkermansia Company, visit theakkermansiacompany.com.
About Akkermansia
The Akkermansia Company, an international leader in the development of next-generation probiotic and postbiotic supplements, is on a mission to shift the focus of the microbiome health paradigm from symptoms to root causes. Founded by Professor Willem M. de Vos and his team, the company discovered, named, patented and developed Akkermansia muciniphila MucT™, which plays a major role in maintaining a healthy gut microbiome. After launching in Europe in 2021, the company's first supplement is now available on Amazon and through healthcare professional channels in the United States. For more information, visit theakkermansiacompany.com. Also, follow The Akkermansia Company on Facebook and Instagram.
Media Contact:
Lisa Lazarczyk, LAZ PR
Phone: 617.838.7327 or lisa@lazpr.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a021479e-4d8d-4299-843d-6d8e8d4e2caf
Akkermansia healthy weight
